{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:32:51Z","timestamp":1793406771079,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-INBS-0006"],"award-info":[{"award-number":["ANR-11-INBS-0006"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["31618719"],"award-info":[{"award-number":["31618719"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["T.0141.19"],"award-info":[{"award-number":["T.0141.19"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To date, a biopsy is mandatory to evaluate parenchymal inflammation in the liver. Here, we evaluated whether molecular imaging of vascular cell adhesion molecule-1 (VCAM-1) could be used as an alternative non-invasive tool to detect liver inflammation in the setting of chronic liver disease. To do so, we radiolabeled anti-VCAM-1 nanobody (\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-cAbVCAM1-5) and used single-photon emission computed tomography (SPECT) to quantify liver uptake in preclinical models of non-alcoholic fatty liver disease (NAFLD) with various degree of liver inflammation: wild-type mice fed a normal or high-fat diet (HFD), FOZ fed a HFD and C57BL6\/J fed a choline-deficient or -supplemented HFD.\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-cAbVCAM1-5 uptake strongly correlates with liver histological inflammatory score and with molecular inflammatory markers. The diagnostic power to detect any degree of liver inflammation is excellent (AUROC 0.85\u20130.99). These data build the rationale to investigate\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-cAbVCAM1-5 imaging to detect liver inflammation in patients with NAFLD, a largely unmet medical need.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-36776-7","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T08:03:03Z","timestamp":1677225783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody"],"prefix":"10.1038","volume":"14","author":[{"given":"Maxime","family":"Nachit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Montemagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Clerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Briand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Bacot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Devoogdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-4668","authenticated-orcid":false,"given":"Cindy","family":"Serdjebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Sulpice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Broisat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7934-6693","authenticated-orcid":false,"given":"Isabelle A.","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Perret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"36776_CR1","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","volume":"18","author":"AM Moon","year":"2020","unstructured":"Moon, A. M., Singal, A. G. & Tapper, E. B. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin. Gastroenterol. Hepatol. 18, 2650\u20132666 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"36776_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","volume":"16","author":"AJ Sanyal","year":"2019","unstructured":"Sanyal, A. J. Past, present and future perspectives in nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 16, 377\u2013386 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"36776_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama, Y. & Brenner, D. A. Liver inflammation and fibrosis. J. Clin. Invest. 127, 55\u201364 (2017).","journal-title":"J. Clin. Invest."},{"key":"36776_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MOG.0000000000000621","volume":"36","author":"A Khalifa","year":"2020","unstructured":"Khalifa, A. & Rockey, D. C. The utility of liver biopsy in 2020. Curr. Opin. Gastroenterol. 36, 184\u2013191 (2020).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"36776_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jcp.2005.036020","volume":"60","author":"S Skripenova","year":"2007","unstructured":"Skripenova, S., Trainer, T. D., Krawitt, E. L. & Blaszyk, H. Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. J. Clin. Pathol. 60, 321\u2013324 (2007).","journal-title":"J. Clin. Pathol."},{"key":"36776_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1055\/s-0039-3401031","volume":"40","author":"M Buti","year":"2020","unstructured":"Buti, M., Riveiro-Barciela, M., Rodr\u00edguez-Fr\u00edas, F., Tabernero, D. & Esteban, R. Role of Biomarkers in Guiding Cure of Viral Hepatitis B. Semin. Liver Dis. 40, 49\u201360 (2020).","journal-title":"Semin. Liver Dis."},{"key":"36776_CR7","first-page":"476","volume":"0","author":"LJM Heyens","year":"2021","unstructured":"Heyens, L. J. M., Busschots, D., Koek, G. H., Robaeys, G. & Francque, S. Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment. Front. Med. 0, 476 (2021).","journal-title":"Front. Med."},{"key":"36776_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera, L., Friedrich-Rust, M. & Loomba, R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156, 1264\u20131281.e4 (2019).","journal-title":"Gastroenterology"},{"key":"36776_CR9","doi-asserted-by":"publisher","unstructured":"Davison, B. A. et al. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. J. Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2020.06.025 (2020).","DOI":"10.1016\/j.jhep.2020.06.025"},{"key":"36776_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","volume":"13","author":"MW Robinson","year":"2016","unstructured":"Robinson, M. W., Harmon, C. & O\u2019Farrelly, C. Liver immunology and its role in inflammation and homeostasis. Cell. Mol. Immunol. 13, 267\u2013276 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"36776_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1440-1711.2002.01062.x","volume":"80","author":"PF Lalor","year":"2002","unstructured":"Lalor, P. F., Shields, P., Grant, A. J. & Adams, D. H. Recruitment of lymphocytes to the human liver. Immunol. Cell Biol. 80, 52\u201364 (2002).","journal-title":"Immunol. Cell Biol."},{"key":"36776_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra, F. & Tacke, F. Roles for chemokines in liver disease. Gastroenterology 147, 577\u2013594.e1 (2014).","journal-title":"Gastroenterology"},{"key":"36776_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jhep.2007.12.005","volume":"48","author":"W-Y Lee","year":"2008","unstructured":"Lee, W.-Y. & Kubes, P. Leukocyte adhesion in the liver: distinct adhesion paradigm from other organs. J. Hepatol. 48, 504\u2013512 (2008).","journal-title":"J. Hepatol."},{"key":"36776_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1126\/science.2588007","volume":"246","author":"G Rice","year":"1989","unstructured":"Rice, G. & Bevilacqua, M. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246, 1303\u20131306 (1989).","journal-title":"Science"},{"key":"36776_CR15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/0092-8674(89)90775-7","volume":"59","author":"L Osborn","year":"1989","unstructured":"Osborn, L. et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59, 1203\u20131211 (1989).","journal-title":"Cell"},{"key":"36776_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yexcr.2017.06.003","volume":"358","author":"C Cerutti","year":"2017","unstructured":"Cerutti, C. & Ridley, A. J. Endothelial cell-cell adhesion and signaling. Exp. Cell Res. 358, 31\u201338 (2017).","journal-title":"Exp. Cell Res."},{"key":"36776_CR17","doi-asserted-by":"crossref","unstructured":"Chen, C. C. & Manning, A. M. Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-\u03baB. Inflammation: Mechanisms and Therapeutics 135\u2013141 (Birkh\u00e4user Basel, 1995).","DOI":"10.1007\/978-3-0348-7343-7_12"},{"key":"36776_CR18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1053\/j.gastro.2005.09.004","volume":"129","author":"A dela Pe\u00f1a","year":"2005","unstructured":"dela Pe\u00f1a, A. et al. NF-\u03baB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129, 1663\u20131674 (2005).","journal-title":"Gastroenterology"},{"key":"36776_CR19","doi-asserted-by":"crossref","unstructured":"Furuta, K. et al. Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis. J. Clin. Invest. 131, e143690 (2021).","DOI":"10.1172\/JCI143690"},{"key":"36776_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/CIRCRESAHA.112.265140","volume":"110","author":"A Broisat","year":"2012","unstructured":"Broisat, A. et al. Nanobodies targeting mouse\/human VCAM1 for the nuclear imaging of atherosclerotic lesions. Circ. Res. 110, 927\u2013937 (2012).","journal-title":"Circ. Res."},{"key":"36776_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.metabol.2016.12.013","volume":"69","author":"T Honda","year":"2017","unstructured":"Honda, T. et al. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice. Metabolism 69, 177\u2013187 (2017).","journal-title":"Metabolism"},{"key":"36776_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O. & Heikenwalder, M. From NASH to HCC: current concepts and future challenges. Nat. Rev. Gastroenterol. Hepatol. 16, 411\u2013428 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"36776_CR23","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jhep.2021.06.034","volume":"75","author":"TG Simon","year":"2021","unstructured":"Simon, T. G. et al. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality. J. Hepatol. 75, 1034\u20131041 (2021).","journal-title":"J. Hepatol."},{"key":"36776_CR24","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","volume":"70","author":"TG Simon","year":"2021","unstructured":"Simon, T. G., Roelstraete, B., Khalili, H., Hagstr\u00f6m, H. & Ludvigsson, J. F. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut 70, 1375\u20131382 (2021).","journal-title":"Gut"},{"key":"36776_CR25","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.2967\/jnumed.114.143792","volume":"55","author":"A Broisat","year":"2014","unstructured":"Broisat, A. et al. 99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice. J. Nucl. Med. 55, 1678\u20131684 (2014).","journal-title":"J. Nucl. Med."},{"key":"36776_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hep4.1618","volume":"5","author":"J Vieira Barbosa","year":"2021","unstructured":"Vieira Barbosa, J. & Lai, M. Nonalcoholic fatty liver disease screening in type 2 diabetes mellitus patients in the primary care setting. Hepatol. Commun. 5, 158\u2013167 (2021).","journal-title":"Hepatol. Commun."},{"key":"36776_CR27","doi-asserted-by":"crossref","unstructured":"Dong, X. C. PNPLA3\u2014a potential therapeutic target for personalized treatment of chronic liver disease. Front. Med. 6, 304(2019).","DOI":"10.3389\/fmed.2019.00304"},{"key":"36776_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jhep.2019.10.024","volume":"72","author":"VW-SS Wong","year":"2020","unstructured":"Wong, V. W.-S. S. Predicting NASH response with liver fat: are we back to square one? J. Hepatol. 72, 386\u2013388 (2020).","journal-title":"J. Hepatol."},{"key":"36776_CR29","doi-asserted-by":"crossref","unstructured":"Hiroyama, S. et al. Quantitative evaluation of hepatic integrin \u03b1v\u03b23 expression by positron emission tomography imaging using 18F-FPP-RGD2 in rats with non-alcoholic steatohepatitis. EJNMMI Res. 10, 118 (2020).","DOI":"10.1186\/s13550-020-00704-3"},{"key":"36776_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.nucmedbio.2020.11.006","volume":"93","author":"M Rosestedt","year":"2021","unstructured":"Rosestedt, M. et al. Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1. Nucl. Med. Biol. 93, 54\u201362 (2021).","journal-title":"Nucl. Med. Biol."},{"key":"36776_CR31","doi-asserted-by":"crossref","unstructured":"Sakai, T. et al. Sensitive and early detection of mitochondrial dysfunction in the liver of NASH model mice by PET imaging with 18F-BCPP-BF. EJNMMI Res. 8, 61 (2018).","DOI":"10.1186\/s13550-018-0420-6"},{"key":"36776_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11307-016-0976-3","volume":"19","author":"F Zheng","year":"2017","unstructured":"Zheng, F. et al. Molecular imaging with Kupffer cell-targeting nanobodies for diagnosis and prognosis in mouse models of liver pathogenesis. Mol. Imaging Biol. 19, 49\u201358 (2017).","journal-title":"Mol. Imaging Biol."},{"key":"36776_CR33","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bbrc.2006.02.032","volume":"342","author":"T Arsov","year":"2006","unstructured":"Arsov, T. et al. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. Biochem. Biophys. Res. Commun. 342, 1152\u20131159 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"36776_CR34","doi-asserted-by":"publisher","first-page":"W151","DOI":"10.2214\/AJR.17.19391","volume":"211","author":"PJ Pickhardt","year":"2018","unstructured":"Pickhardt, P. J., Graffy, P. M., Reeder, S. B., Hernando, D. & Li, K. Quantification of liver fat content with unenhanced MDCT: phantom and clinical correlation with MRI proton density fat fraction. Am. J. Roentgenol. 211, W151\u2013W157 (2018).","journal-title":"Am. J. Roentgenol."},{"key":"36776_CR35","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"36776_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcsm.12646","volume":"12","author":"M Nachit","year":"2021","unstructured":"Nachit, M. et al. Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models. J. Cachexia Sarcopenia Muscle 12, 1\u201315 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"36776_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41374-019-0315-9","volume":"100","author":"M De Rudder","year":"2020","unstructured":"De Rudder, M. et al. Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD\/NASH. Lab. Invest. 100, 147\u2013160 (2020).","journal-title":"Lab. Invest."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36776-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36776-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36776-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T08:06:10Z","timestamp":1677225970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36776-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36776"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-36776-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A. Broisat, C. Ghezzi and N. Devoogdt are inventors on the patent on VCAM-1 Nanobodies (PCT\/EP2012\/066348), granted amongst other countries in US and Europe (US9771423B2 and EP2748196B8). Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1062"}}